Enorama Pharma AB (ERMA) — Financial Flexibility Index
Enorama Pharma AB (ERMA) has a Financial Flexibility Index of -0.20x as of March 2026. Free cash flow of Skr-12.09 Million (operating CF Skr-12.09 Million minus capex Skr0.00) represents 0% of total liabilities (Skr59.58 Million). Check Enorama Pharma AB investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Enorama Pharma AB Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Enorama Pharma AB across 12 annual periods. For the full cash flow conversion analysis, see Enorama Pharma AB operating cash flow efficiency.
Annual Financial Flexibility Index for Enorama Pharma AB (2014–2025)
Year-by-year free cash flow to debt coverage for Enorama Pharma AB. Explore Enorama Pharma AB cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | Skr0.00 | Skr-59.26 Million | Skr31.71 Million | ▲ +100.0% |
| 2024 | -4.41x | Skr-35.70 Million | Skr-35.70 Million | Skr8.09 Million | ▼ -58.4% |
| 2023 | -2.79x | Skr-41.35 Million | Skr-41.35 Million | Skr14.85 Million | ▼ -45.3% |
| 2022 | -1.92x | Skr-32.96 Million | Skr-32.96 Million | Skr17.20 Million | ▼ -100.0% |
| 2021 | -0.96x | Skr-28.34 Million | Skr-30.16 Million | Skr29.58 Million | ▼ -95.6% |
| 2020 | -0.49x | Skr-19.16 Million | Skr-23.00 Million | Skr39.13 Million | ▲ +22.6% |
| 2019 | -0.63x | Skr-22.39 Million | Skr-26.56 Million | Skr35.40 Million | ▼ -122.9% |
| 2018 | -0.28x | Skr-6.19 Million | Skr-13.36 Million | Skr21.81 Million | ▲ +21.4% |
| 2017 | -0.36x | Skr-2.93 Million | Skr-6.67 Million | Skr8.13 Million | ▲ +22.7% |
| 2016 | -0.47x | Skr-2.12 Million | Skr-6.11 Million | Skr4.55 Million | ▼ -149.9% |
| 2015 | 0.94x | Skr2.47 Million | Skr480.00K | Skr2.64 Million | ▼ -42.8% |
| 2014 | 1.63x | Skr1.69 Million | Skr307.00K | Skr1.03 Million | — |